Chief Medical Officer · Neurogene Inc. (NGNE)

Julie Jordan

Julie Jordan, Chief Medical Officer at Neurogene Inc., received total compensation of $1472307 for fiscal year 2025. Her disclosed pay includes a base salary of $496800, a cash bonus of $198720, and stock-based compensation of $775968.

A named executive officer of Neurogene in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,472,307

FY2024: $2,460,036

3rd of 3 named executive officers at Neurogene by FY2025 total.

3 named officers on file for Neurogene, FY2025

See an example →

What this number hides

The filing gives the total. Neurogene’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Neurogene’s whole pay program stands against its peers

  • Neurogene’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NGNE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2026 (DEF 14A).

Free

Get Julie Jordan’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Julie Jordan and every company like it: Velarion Intel, free for 3 days, no card →

Julie Jordan compensation by year

Neurogene Summary Compensation Table · all 2 fiscal years held
In US dollars, as Neurogene reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$460,000$496,800
Bonus$184,636$198,720
Stock awards$0$135,576
Option awards$1,809,000$640,392
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$6,400$819
Total$2,460,036$1,472,307

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Neurogene Inc. DEF 14A filed April 16, 2026, accession 0001404644-26-000027, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Neurogene Inc. filed document, accession 0001404644-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2026.

$2.5M
$1.5M
FY24
FY25
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU8,400$173,040—
Option39,063—$32.30
Option50,300—$16.14

Per the Outstanding Equity Awards at Fiscal Year-End table in Neurogene Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Neurogene’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Rachel McMinnFounder and Chief Executive Officer$3,209,553
Christine MikailPresident and Chief Financial Officer$2,754,458
Julie Jordan · this pageChief Medical Officer$1,472,307

Julie Jordan's compensation dossier, Neurogene

You have read Julie Jordan's totals and holdings. The dossier adds each equity grant Neurogene disclosed for Julie Jordan and Neurogene's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Neurogene compensation record

free company brief

This page is one person within Neurogene's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Neurogene's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Neurogene's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order NGNE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Julie Jordan's compensation dossier